Trials / Completed
CompletedNCT00596102
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,258 (actual)
- Sponsor
- Valneva Austria GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study investigates the long term safety and immunogenicity of the Japanese Encephalitis vaccine IC51 up to month 60.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Japanese Encephalitis purified inactivated vaccine | Japanese Encephalitis purified inactivated vaccine |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2011-03-01
- First posted
- 2008-01-16
- Last updated
- 2014-07-30
- Results posted
- 2014-07-30
Source: ClinicalTrials.gov record NCT00596102. Inclusion in this directory is not an endorsement.